FrancophonIA/ELRC3.0 huggingface dataset:
English: What are the risks associated with Shingrix?
Croatian: Koji su rizici povezani s lijekom Shingrix?
English: In the first study with adults aged 50 years and over, 7,695 received Shingrix and 7,710 received placebo.
Croatian: Ispitanici u prvom ispitivanju bile su odrasle osobe u dobi od 50 godina i više, od kojih je 7 695 osoba primalo lijek Shingrix, a 7 710 placebo.
English: Shingrix has been designed to prevent shingles in people who have been in contact with the varicella zoster virus (the virus that causes chickenpox) and have already developed antibodies against the virus.
Croatian: Lijek Shingrix osmišljen je tako da sprječava herpes zoster u ljudi koji su došli u kontakt s virusom varicella zoster (virus koji prouzročuje vodene kozice) i koji su već razvili protutijela na taj virus.
English: Looking at the results for adults in this age group from both studies together, 25 adults out of 8,250 who received Shingrix had shingles within 4 years after vaccination compared with 284 out of 8,346 who received placebo.
Croatian: Kad bi se rezultati za odrasle osobe te dobne skupine iz oba ispitivanja promatrali zajedno, u razdoblju od 4 godine nakon cijepljenja, herpes zoster imalo je 25 od 8 250 odraslih osoba koje su primale lijek Shingrix, u odnosu na 284 od 8 346 odraslih osoba koje su primale placebo.
English: Patients given Shingrix will be able to produce antibodies against the virus more quickly when the virus is reactivated and they will therefore have protection against the disease.
Croatian: U trenutku reaktivacije virusa bolesnici koji primaju lijek Shingrix moći će brže stvarati protutijela na virus te će stoga biti zaštićeni od bolesti.
English: How does Shingrix work?
Croatian: Kako djeluje Shingrix?
English: This indicates that Shingrix prevented 97% of shingles cases and 100% of cases of post-herpetic neuralgia in this study.
Croatian: Iz toga je vidljivo da je u okviru tog ispitivanja lijek Shingrix spriječio 97 % slučajeva herpes zostera i 100 % slučajeva postherpetičke neuralgije.
English: What benefits of Shingrix have been shown in studies?
Croatian: Koje su koristi lijeka Shingrix dokazane u ispitivanjima?
English: The second study involved adults aged 70 and over who received either Shingrix or placebo.
Croatian: Ispitanici drugog ispitivanja bile su odrasle osobe u dobi od 70 godina i više koje su primale lijek Shingrix ili placebo.
English: How is Shingrix used?
Croatian: Kako se Shingrix koristi?
English: Shingrix has been shown to be effective at preventing shingles and post-herpetic neuralgia.
Croatian: Utvrđeno je da lijek Shingrix učinkovito sprječava herpes zoster i postherpetičku neuralgiju.
English: For the full list of side effects and restrictions with Shingrix, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja pri primjeni lijeka Shingrix potražite u uputi o lijeku.
English: This indicates that Shingrix prevented 91% of shingles cases and 89% of cases of post-herpetic neuralgia in adults aged 70 years and older.
Croatian: Iz toga je vidljivo da je u odraslih osoba u dobi od 70 godina ili više lijek Shingrix spriječio 91 % slučajeva herpes zostera i 89 % slučajeva postherpetičke neuralgije.
English: After just over 3 years on average, 6 adults had had shingles in the Shingrix group compared with 210 in the placebo group.
Croatian: Nakon što je u prosjeku prošlo samo nešto više od 3 godine, herpes zoster imalo je 6 odraslih osoba u skupini koja je primala lijek Shingrix, u odnosu na 210 osoba u skupini koja je primala placebo.
English: After 4 years, 4 adults had had post-herpetic neuralgia in the Shingrix group compared with 36 in the placebo group.
Croatian: Nakon 4 godine postherpetičku neuralgiju imale su 4 odrasle osobe u skupini koja je primala lijek Shingrix, u odnosu na 36 odraslih osoba u skupini koja je primala placebo.
English: After almost 4 years, nobody had had post-herpetic neuralgia in the Shingrix group compared with 18 in the placebo group.
Croatian: Nakon gotovo 4 godine, u skupini koja je primala lijek Shingrix nitko nije imao postherpetičku neuralgiju, u odnosu na 18 slučajeva postherpetičke neuralgije u skupini koja je primala placebo.
English: Shingrix has been shown to be highly effective at preventing shingles and post-herpetic neuralgia across all age groups older than 50 years for at least 4 years after vaccination.
Croatian: Dokazano je da u razdoblju od najmanje 4 godine nakon cijepljenja lijek Shingrix veoma učinkovito sprječava herpes zoster i postherpetičku neuralgiju u svim dobnim skupinama iznad 50 godina.
English: Shingles is a painful, blistering rash caused by the reactivation of the virus that causes chickenpox.
Croatian: Herpes zoster bolan je osip praćen pojavom mjehurića na koži, a prouzročuje ga reaktivacija virusa koji izaziva vodene kozice.
English: The recommended dose is one inhalation per day at the same time each day.
Croatian: Preporučena doza je jedna inhalacija jednom dnevno u isto vrijeme svakog dana.
English: 1 Previously known as Incruse.
Croatian: 1 Prethodno poznat kao Incruse.
English: This overview was last updated in 09-2018.
Croatian: Ovaj pregled informacija posljednji je put ažuriran u 09. 2018.
English: Further information on Incruse Ellipta can be found on the Agency's website: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
Croatian: Više informacija o lijeku Incruse Ellipta nalazi se na internetskim stranicama Agencije: ema.europa.eu/Find medicine/Human medicines/European public assessment reports.
English: The main measure of effectiveness was based on changes in the patients' forced expiratory volumes (FEV1, the maximum volume of air a person can breathe out in one second).
Croatian: Glavna mjera djelotvornosti temeljila se na promjenama u forsiranim izdisajnim volumenima bolesnika (FEV1, maksimalni volumen zraka koji osoba može izdahnuti u jednoj sekundi).
English: It is available as an inhalation powder in a portable inhaler device.
Croatian: Dostupan je kao prašak za inhalaciju u prijenosnom inhalatoru.
English: It works by blocking some receptors called muscarinic receptors, which control the contraction of muscles.
Croatian: Djeluje blokirajući određene receptore, zvane muskarinski receptori, koji kontroliraju kontrakciju mišića.
English: For detailed information on how to use the inhaler correctly, see the instructions in the package leaflet or contact your doctor or pharmacist.
Croatian: Detaljne informacije o pravilnoj upotrebi inhalatora pogledajte u uputi o lijeku ili se obratite svojem liječniku ili ljekarniku.
English: Incruse Ellipta was investigated in four main studies involving over 4,000 patients.
Croatian: Lijek Incruse Ellipta ispitan je u četirima glavnim ispitivanjima u kojima je sudjelovalo više od 4 000 bolesnika.
English: Incruse Ellipta0F (umeclidinium bromide) EMA/593792/2018
Croatian: Incruse Ellipta0F (umeklidinijev bromid) EMA/593792/2018
English: The most common side effects with Incruse Ellipta (which may affect up to 1 in 10 people) are headache, nasopharyngitis (inflammation of the nose and throat), upper respiratory tract infection (nose and throat infection), sinusitis (inflammation of the sinuses), cough, urinary tract infection (infection of the structures that carry urine), and tachycardia (increased heart rate).
Croatian: Najčešće nuspojave lijeka Incruse Ellipta (koje se mogu pojaviti u do 1 na 10 osoba) su glavobolja, nazofaringitis (upala nosa i grla), infekcija gornjeg dišnog sustava (infekcija nosa i grla), sinusitis (upala sinusa), kašalj, infekcija urinarnog trakta (infekcija struktura kojima se prenosi mokraća) i tahikardija (ubrzanje srčane frekvencije).
English: Each inhalation provides 65 micrograms of umeclidinium bromide equivalent to 55 micrograms of umeclidinium.
Croatian: Svaka inhalacija pruža 65 mikrograma umeklidinijeva bromida, što odgovara dozi od 55 mikrograma umeklidinija.
English: The studies also showed an improvement in symptoms such as breathlessness and wheezing.
Croatian: Ispitivanja su također pokazala ublažavanje simptoma poput nedostatka daha i piskanja.
English: Results showed that Incruse Ellipta improved lung function by an average FEV1 of 127 ml more than placebo after 12 weeks of treatment and by 115 ml more than placebo after 24 weeks of treatment.
Croatian: Rezultati su pokazali da je lijekom Incruse Ellipta poboljšana funkcija pluća za prosječni FEV1 za 127 ml više u odnosu na placebo nakon 12 tjedana liječenja te za 115 ml više nakon 24 tjedna liječenja.
English: As medicines of the same class as Incruse Ellipta may have an effect on the heart and blood vessels in the brain, the company that markets Incruse Ellipta will carry out a long-term study in patients to collect further information on its safety in comparison with tiotropium.
Croatian: Budući da lijekovi istog razreda kao i lijek Incruse Ellipta mogu imati učinak na srce i krvne žile u mozgu, tvrtka koja na tržište stavlja lijek Incruse Ellipta provest će dugoročno ispitivanje u bolesnika kako bi prikupila dodatne informacije o sigurnosti lijeka u usporedbi s tiotropijem.
English: Side effects reported with Incruse Ellipta are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Incruse Ellipta pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: Incruse Ellipta1 (umeclidinium bromide)
Croatian: Incruse Ellipta1 (umeklidinijev bromid)
English: Incruse Ellipta received a marketing authorisation valid throughout the EU on 28 April 2014.
Croatian: Lijek Incruse Ellipta dobio je odobrenje za stavljanje lijeka u promet koje je na snazi u Europskoj uniji od 28. travnja 2014.
English: What measures are being taken to ensure the safe and effective use of Incruse Ellipta?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Incruse Ellipta?
English: A double dose of Incruse Ellipta only showed small improvements compared with a single dose, which were not considered relevant.
Croatian: Kada je lijek Incruse Ellipta primijenjen u dvostrukoj dozi, dokazana su tek malena poboljšanja u usporedbi s jednom dozom, te se ne smatraju relevantnima.
English: In the study comparing Incruse Ellipta with tiotropium, FEV1 improvements over 24 weeks were similar for both medicines.
Croatian: U ispitivanju u kojem je lijek Incruse Ellipta uspoređen s tiotropijem, poboljšanja FEV1 tijekom 24 tjedna bila su slična za oba lijeka.
English: Incruse Ellipta is a medicine used to relieve the symptoms of chronic obstructive pulmonary disease (COPD) in adults.
Croatian: Incruse Ellipta je lijek koji se primjenjuje za ublažavanje simptoma kronične opstruktivne plućne bolesti (KOPB) u odraslih osoba.
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Incruse Ellipta have also been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i djelotvorne primjene lijeka Incruse Ellipta nalaze se također u sažetku opisa svojstava lijeka i u uputi o lijeku.
English: The Agency also noted that there were no major safety concerns with Incruse Ellipta, with side effects being manageable and similar to other medicines of the same class (antimuscarinic bronchodilators).
Croatian: Agencija je također zaključila da nisu ustanovljeni razlozi za ozbiljnu zabrinutost u pogledu sigurnosti lijeka Incruse Ellipta te da se nuspojave mogu liječiti i da su slične kao kod ostalih lijekova istog razreda (antimuskarinski lijekovi s bronhodilatacijskim učinkom).
English: As for all medicines, data on the use of Incruse Ellipta are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Incruse Ellipta kontinuirano se prate.
English: Other information about Incruse Ellipta
Croatian: Ostale informacije o lijeku Incruse Ellipta
English: The Agency concluded that Incruse Ellipta was shown to be effective at improving lung function and symptoms of COPD.
Croatian: Agencija je zaključila da je lijek Incruse Ellipta dokazano djelotvoran pri poboljšanju funkcije pluća i ublažavanju simptoma KOPBa.
English: The European Medicines Agency decided that Incruse Ellipta's benefits are greater than its risks and it can be authorised for use in the EU.
Croatian: Europska agencija za lijekove zaključila je da koristi od lijeka Incruse Ellipta nadmašuju s njim povezane rizike te da se lijek može odobriti za primjenu u Europskoj uniji.
English: An overview of Incruse Ellipta and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Incruse Ellipta i zašto je odobren u EU-u
English: Incruse Ellipta is used for maintenance (regular) treatment.
Croatian: Incruse Ellipta primjenjuje se kao (redovita) terapija održavanja.
English: The active substance in Incruse Ellipta, umeclidinium bromide, is a muscarinic receptor antagonist.
Croatian: Djelatna tvar lijeka Incruse Ellipta, umeklidinijev bromid, antagonist je muskarinskih receptora.
English: Three studies compared Incruse Ellipta with placebo (a dummy treatment), while one study compared Incruse Ellipta with tiotropium (another medicine for COPD).
Croatian: U trima ispitivanjima lijek Incruse Ellipta uspoređen je s placebom (prividnim liječenjem), dok je u jednom ispitivanju lijek Incruse Ellipta uspoređen s tiotropijem (drugim lijekom protiv KOPBa).
English: What is Incruse Ellipta and what is it used for?
Croatian: Što je Incruse Ellipta i za što se primjenjuje?
English: What are the risks associated with Incruse Ellipta?
Croatian: Koji su rizici povezani s lijekom Incruse Ellipta?
English: When umeclidinium bromide is inhaled, it relaxes the muscles of the airways.
Croatian: Prilikom inhalacije umeklidinijeva bromida dolazi do opuštanja mišića dišnih putova.
English: Incruse Ellipta contains the active substance umeclidinium bromide.
Croatian: Incruse Ellipta sadržava djelatnu tvar umeklidinijev bromid.
English: Incruse Ellipta can only be obtained with a prescription.
Croatian: Incruse Ellipta izdaje se samo na liječnički recept.
English: Why is Incruse Ellipta authorised in the EU?
Croatian: Zašto je lijek Incruse Ellipta odobren u EU-u?
English: What benefits of Incruse Ellipta have been shown in studies?
Croatian: Koje su koristi od lijeka Incruse Ellipta utvrđene u ispitivanjima?
English: For the full list of side effects and restrictions with Incruse Ellipta, see the package leaflet.
Croatian: Potpuni popis nuspojava i ograničenja pri primjeni lijeka Incruse Ellipta potražite u uputi o lijeku.
English: How is Incruse Ellipta used?
Croatian: Kako se Incruse Ellipta primjenjuje?
English: How does Incruse Ellipta work?
Croatian: Kako djeluje Incruse Ellipta?
English: Unopened vial 3 years
Croatian: Neotvorena bočica 3 godine.
English: Instructions for use, handling and disposal
Croatian: Upute za uporabu, rukovanje i odlaganje
English: 20 November 2015
Croatian: Datum prvog odobrenja: 20. studenog 2015.
English: If not used immediately, in-use storage times and conditions prior to use are the responsibility of the user and would normally not be longer than 24 hours at 2°C to 8°C.
Croatian: Ako se ne primijeni odmah, vrijeme i uvjeti čuvanja lijeka prije primjene odgovornost su korisnika i ne bi trebali biti dulji od 24 sata na temperaturi od 2°C do 8°C.
English: Cisplatin is also given by infusion into one of your veins, and is given approximately 30 minutes after the infusion of Pemetrexed Hospira has finished.
Croatian: Cisplatin se također primjenjuje infuzijom u jednu od vena i daje se približno 30 minuta nakon završetka infuzije lijeka Pemetreksed Hospira.
English: Creatinine clearance should be ≥ 45 ml/min.
Croatian: Klirens kreatinina mora biti ≥45 ml/min.
English: Calculate the dose and the number of Pemetrexed Hospira vials needed.
Croatian: Izračunati dozu i potreban broj bočica lijeka Pemetreksed Hospira.
English: Reconstituted and infusion solution: The product should be used immediately.
Croatian: Rekonstituirana otopina i otopina za infuziju: Lijek se mora odmah upotrijebiti.
English: The European Medicines Agency has waived the obligation to submit the results of studies with the reference medicinal product containing pemetrexed in all subsets of the paediatric population for the granted indications (see section 4.2 for information on paediatric use).
Croatian: Europska agencija za lijekove je izuzela obvezu podnošenja rezultata ispitivanja referentnog lijeka koji sadrži pemetreksed u svim podskupinama pedijatrijske populacije (vidjeti dio 4.2 za informacije o pedijatrijskoj primjeni).
English: What Pemetrexed Hospira is and what it is used for
Croatian: Što je Pemetreksed Hospira i za što se koristi
English: You will also receive an injection of vitamin B12 (1,000 micrograms) in the week before administration of Pemetrexed Hospira and then approximately every 9 weeks (corresponding to 3 courses of Pemetrexed Hospira treatment).
Croatian: Također ćete dobiti injekciju vitamina B12 (1000 mikrograma) u tjednu prije primjene lijeka Pemetreksed Hospira i zatim otprilike svakih 9 tjedana (što odgovara 3 ciklusa liječenja lijekom Pemetreksed Hospira).
English: Concomitant use contraindicated: Yellow fever vaccine: risk of fatal generalised vaccinale disease (see section 4.3).
Croatian: Kontraindicirana je istodobna primjena: cjepiva protiv žute groznice zbog rizika od smrtonosne generalizirane vakcinalne bolesti (vidjeti dio 4.3).
English: You must take at least 5 doses during the seven days before the first dose of Pemetrexed Hospira.
Croatian: Morate uzeti barem 5 doza tijekom 7 dana prije prve doze lijeka Pemetreksed Hospira.
English: You will always receive Pemetrexed Hospira by infusion into one of your veins.
Croatian: Lijek Pemetreksed Hospira uvijek ćete primiti infuzijom u jednu od vena.
English: Pemetrexed Hospira is a medicine used in the treatment of cancer.
Croatian: Pemetreksed Hospira je lijek koji se koristi za liječenje raka.
English: If you have an accumulation of fluid around your lungs, your doctor may decide to remove the fluid before giving you Pemetrexed Hospira.
Croatian: Ako imate nakupljenu tekućinu oko pluća, liječnik može odlučiti ukloniti tu tekućinu prije primjene lijeka Pemetreksed Hospira.
English: If you currently have or have previously had problems with your kidneys, talk to your doctor or hospital pharmacist as you may not be able to receive Pemetrexed Hospira.
Croatian: Ako trenutno imate ili ste prethodno imali problema s bubrezima, obratite se svom liječniku ili bolničkom ljekarniku jer možda nećete smjeti primati lijek Pemetreksed Hospira.
English: This leaflet was last revised in month YYYY.
Croatian: Uputa je zadnji puta revidirana u mjesec GGGG.
English: Concomitant use not recommended: Live attenuated vaccines (except yellow fever, for which concomitant use is contraindicated): risk of systemic, possibly fatal, disease.
Croatian: Ne preporučuje se istodobna primjena: živih atenuiranih cjepiva (osim cjepiva protiv žute groznice, čija je istodobna primjena kontraindicirana), zbog rizika od sustavne bolesti koja može biti smrtonosna.
English: Pemetrexed Hospira can have a minor or moderate influence on ability to drive and use machines.
Croatian: Pemetreksed Hospira malo ili umjereno utječe na sposobnost upravljanja vozilima i rada sa strojevima.
English: The dose of Pemetrexed Hospira is 500 milligrams for every square metre of your body's surface area.
Croatian: Doza lijeka Pemetreksed Hospira je 500 miligrama po svakom kvadratnom metru Vaše površine tijela.
English: Before each infusion you will have samples of your blood taken to evaluate if you have sufficient kidney and liver function and to check that you have enough blood cells to receive Pemetrexed Hospira.
Croatian: Prije svake infuzije uzet će Vam se uzorak krvi kako bi se provjerilo jesu li Vam bubrežna ili jetrena funkcija dovoljno dobre i imate li dovoljno krvnih stanica da biste primili lijek Pemetreksed Hospira.
English: Reconstitute and dilute before use.
Croatian: Rekonstituirati i razrijediti prije primjene.
English: Pemetrexed is primarily eliminated in the urine, with 70% to 90% of the administered dose being recovered unchanged in urine within the first 24 hours following administration.
Croatian: Lijek se prvenstveno eliminira mokraćom, pri čemu se 70% do 90% primijenjene doze nađe u mokraći u nepromijenjenu obliku tijekom prva 24 sata nakon primjene.
English: What you need to know before you use Pemetrexed Hospira
Croatian: Što morate znati prije nego počnete primjenjivati Pemetreksed Hospira
English: Corticosteroids: your doctor will prescribe you steroid tablets (equivalent to 4 milligram of dexamethasone twice a day) that you will need to take on the day before, on the day of, and the day after Pemetrexed Hospira treatment.
Croatian: Kortikosteroidi: liječnik će Vam propisati tablete kortikosteroida (ekvivalentne dozi deksametazona od 4 mg dvaput na dan) koje ćete morati uzeti dan prije, na sam dan i dan nakon primjene lijeka Pemetreksed Hospira.
English: Other medicines and Pemetrexed Hospira
Croatian: Drugi lijekovi i Pemetreksed Hospira
English: When using Pemetrexed Hospira in combination with cisplatin:
Croatian: Kad se Pemetreksed Hospira primjenjuje u kombinaciji s cisplatinom:
English: Hospira UK Limited
Croatian: Proizvođač Hospira UK Limited Horizon
English: A significant increase in the incidence of possibly study-drug-related Grade 3/4 neutropenia was observed with longer exposure to pemetrexed (≤6 cycles: 3.3%, >6 cycles: 6.4%: p=0.046).
Croatian: Zabilježeno je značajno povećanje incidencije neutropenije stupnja 3/4, koja je mogla biti povezana s lijekom, pri duljoj izloženosti pemetreksedu (≤ 6 ciklusa: 3,3%, > 6 ciklusa: 6,4%; p = 0,046).
English: • Fever or infection (common): if you have a temperature of 38ºC or greater, sweating or other signs of infection (since you might have fewer white blood cells than normal which is very common).
Croatian: • vrućicu ili infekciju (često): ako Vam je tjelesna temperatura 38°C ili viša, ako se znojite ili imate neke druge znakove infekcije (jer broj bijelih krvnih stanica može biti niži od normalnog, što je vrlo česta pojava).
English: It has been reported that pemetrexed may cause fatigue.
Croatian: Prijavljeno je da pemetreksed može izazvati umor.
English: System organ class Frequency Event*
Croatian: Organski sustav Učestalost Događaj*
English: ***Integrated adverse reactions table combines the results of the JMEN pemetrexed maintenance (N=663) and PARAMOUNT continuation pemetrexed maintenance (N=539) studies.
Croatian: ***Integrirana tablica nuspojava objedinjuje rezultate ispitivanja terapije održavanja pemetreksedom JMEN studije (N=663) i kontinuirane terapije održavanja pemetreksedom PARAMOUNT studije (N=539).
English: Pemetrexed Hospira can be prescribed to you if you have lung cancer at an advanced stage if your disease has responded to treatment or it remains largely unchanged after initial chemotherapy.
Croatian: Vam se može propisati ako imate rak pluća u uznapredovaloj fazi i ako je Vaša bolest reagirala na liječenje ili ostala uglavnom nepromijenjena nakon početne kemoterapije.
English: You must continue taking the folic acid for 21 days after the last dose of Pemetrexed Hospira.
Croatian: Morate nastaviti uzimati folatnu kiselinu još najmanje 21 dan nakon posljednje doze lijeka Pemetreksed Hospira.
English: For precautions to be taken before handling or administering Pemetrexed Hospira, see section 6.6.
Croatian: Za mjere opreza koje je potrebno poduzeti prije rukovanja ili primjene lijeka Pemetreksed Hospira vidjeti dio 6.6.
English: HU Pfizer Kft.
Croatian: Pfizer Kft.
English: • If you start feeling chest pain (common) or having a fast heart rate (uncommon).
Croatian: • ako počnete osjećati bolove u prsima (često) ili ubrzano kucanje srca (manje često)
English: Do not use Pemetrexed Hospira - if you are allergic to pemetrexed or any of the other ingredients of this medicine (listed in section 6).
Croatian: - ako ste alergični na pemetreksed ili neki drugi sastojak ovog lijeka (naveden u dijelu 6.)